William C. K. Pomerantz

3.9k citations

99 papers · 2.9k indexed · h-index 33

Co-authors: Samuel H. Gellman Karen Bulloch Nicholas L. Abbott Clifford T. Gee Andrew K. Urick Sean P. Palecek Amy J. Karlsson Neeraj K. Mishra
Topics: Protein Degradation and Inhibitors (34 papers)Multiple Myeloma Research and Treatments (23 papers)Ubiquitin and proteasome pathways (18 papers)
Cited by: Microbiology Molecular Biology Organic Chemistry
Journals: Journal of the American Chemical Society Angewandte Chemie International Edition The Journal of Chemical Physics
Partner nations: United States China Switzerland

In The Last Decade

William C. K. Pomerantz

95 papers receiving 2.9k citations

Peers

Countries citing papers authored by William C. K. Pomerantz

Since Specialization

Citations

This map shows the geographic impact of William C. K. Pomerantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. K. Pomerantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. K. Pomerantz more than expected).

Fields of papers citing papers by William C. K. Pomerantz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William C. K. Pomerantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. K. Pomerantz. The network helps show where William C. K. Pomerantz may publish in the future.

Co-authorship network of co-authors of William C. K. Pomerantz

This figure shows the co-authorship network connecting the top 25 collaborators of William C. K. Pomerantz. A scholar is included among the top collaborators of William C. K. Pomerantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. K. Pomerantz. William C. K. Pomerantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Macrocyclic dihydropyridine analogs as pan-BET BD2-preferred inhibitors 2025 ·European Journal of Medicinal Chemistry ·(unknown),T. Jake Liang,Jonathan Solberg,(unknown),(unknown),Rui Shi,William C. K. Pomerantz,Jon E. Hawkinson,E. Schönbrunn,Gunda I. Georg	0
2	Revealing Organofluorine Contamination in Effluents and Surface Waters with Complementary Analytical Approaches: Fluorine-19 Nuclear Magnetic Resonance Spectroscopy (¹⁹F-NMR) and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) 2025 ·Environmental Science & Technology ·(unknown),William C. K. Pomerantz,James L. Gray,L.E. Hubbard,Dana W. Kolpin,William A. Arnold	0
3	Closing PFAS analytical gaps: Inter-method evaluation of total organofluorine techniques for AFFF-impacted water 2024 ·SHILAP Revista de lepidopterología ·Fuhar Dixit,(unknown),(unknown),Chuhui Zhang,Manmeet W. Pannu,Megan H. Plumlee,(unknown),(unknown),William C. K. Pomerantz,William A. Arnold,Christopher P. Higgins,G. F. Peaslee,Lisa Alvarez‐Cohen,David L. Sedlak,Mohamed Ateia	11
4	Recent progress and structural analyses of domain‐selective BET inhibitors 2023 ·Medicinal Research Reviews ·(unknown),Daniel A. Harki,William C. K. Pomerantz	20
5	Design of Highly Fluorinated Peptides for Cell-based ¹⁹F NMR 2023 ·Bioconjugate Chemistry ·Jiaqian Li,(unknown),Yiao Wang,Huarui Cui,Carston R. Wagner,William C. K. Pomerantz	2
6	Fragment-Based NMR Screening of the BPTF PHD Finger Methyl Lysine Reader Leads to the First Small-Molecule Inhibitors 2023 ·ACS Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Sourav Das,Clifford T. Gee,(unknown),Sergio C. Chai,Richard Lee,Taosheng Chen,Daniel A. Harki,Anang A. Shelat,William C. K. Pomerantz	2
7	Garcinolic Acid Distinguishes Between GACKIX Domains and Modulates Interaction Networks 2023 ·ChemBioChem ·Meghan E. Breen,(unknown),(unknown),(unknown),Matthew J. Henley,(unknown),(unknown),(unknown),Tomasz Cierpicki,William C. K. Pomerantz,Anna K. Mapp	2
8	Development of a Highly Responsive Organofluorine Temperature Sensor for ¹⁹F Magnetic Resonance Applications 2022 ·Analytical Chemistry ·(unknown),Anil K. Pandey,(unknown),Mukunda Mandal,Jiaqian Li,Christopher J. Cramer,Christy L. Haynes,William C. K. Pomerantz	5
9	Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader 2022 ·ACS Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Wenwei Lin,Elizabeth C. Griffith,Richard Lee,Taosheng Chen,Daniel A. Harki,William C. K. Pomerantz	8
10	A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes 2022 ·Journal of Medicinal Chemistry ·Huarui Cui,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Elizabeth C. Griffith,Clifford T. Gee,(unknown),(unknown),Ke Shi,Hideki Aihara,Vijay H. Shah,Richard Lee,Daniel A. Harki,William C. K. Pomerantz	23
11	Development of a single culture E. coli expression system for the enzymatic synthesis of fluorinated tyrosine and its incorporation into proteins 2022 ·Journal of Fluorine Chemistry ·(unknown),(unknown),(unknown),(unknown),Andrew Marshall,Michael J. Smanski,Erin E. Carlson,William C. K. Pomerantz	4
12	¹⁹ F NMR viewed through two different lenses: ligand-observed and protein-observed ¹⁹ F NMR applications for fragment-based drug discovery 2021 ·RSC Chemical Biology ·(unknown),William C. K. Pomerantz	59
13	Autophagy-Dependent Sensitization of Triple-Negative Breast Cancer Models to Topoisomerase II Poisons by Inhibition of the Nucleosome Remodeling Factor 2021 ·Molecular Cancer Research ·Liliya Tyutyunyk‐Massey,Yilun Sun,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Xiaoyan Deng,(unknown),Paula D. Bos,Dipankar Bandyopadhyay,William C. K. Pomerantz,Yves Pommier,David A. Gewirtz,Joseph W. Landry	10
14	Fragment-Based Ligand Discovery Using Protein-Observed ¹⁹F NMR: A Second Semester Organic Chemistry CURE Project 2021 ·Journal of Chemical Education ·Scott K. Bur,William C. K. Pomerantz,(unknown),Clifford T. Gee	10
15	Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors 2021 ·npj Parkinson s Disease ·Anthony R. Braun,Elly E. Liao,(unknown),(unknown),(unknown),(unknown),(unknown),Chih Hung Lo,Roland Brown,Michael D. Evans,William C. K. Pomerantz,Elizabeth Rhoades,Kelvin C. Luk,Rǎzvan L. Cornea,David D. Thomas,Jonathan N. Sachs	25
16	4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Improved Selectivity 2021 ·Journal of Medicinal Chemistry ·Huarui Cui,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Ke Shi,Hideki Aihara,Daniel A. Harki,Grover P. Miller,Joseph J. Topczewski,William C. K. Pomerantz	28
17	Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C‐C Motif Chemokine Ligand 2–Mediated Angiocrine Signaling 2020 ·Hepatology ·Jinhang Gao,Bo Wei,Mengfei Liu,Petra Hirsova,Tejasav S. Sehrawat,Sheng Cao,Xiao Hu,Fei Xue,Usman Yaqoob,Ningling Kang,Huarui Cui,William C. K. Pomerantz,Enis Kostallari,Vijay H. Shah	69
18	Selective N‐Terminal BET Bromodomain Inhibitors by Targeting Non‐Conserved Residues and Structured Water Displacement** 2020 ·Angewandte Chemie International Edition ·Huarui Cui,(unknown),Anil K. Pandey,(unknown),(unknown),(unknown),(unknown),Ke Shi,Hideki Aihara,Daniel A. Harki,William C. K. Pomerantz	36
19	Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase–Bromodomain Inhibitor 2018 ·Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),Neeraj K. Mishra,Huarui Cui,John C. Widen,Norbert Berndt,Jin-Yi Zhu,(unknown),Joseph J. Topczewski,E. Schönbrunn,Daniel A. Harki,William C. K. Pomerantz	51
20	BPTF Maintains Chromatin Accessibility and the Self-Renewal Capacity of Mammary Gland Stem Cells 2017 ·Stem Cell Reports ·Wesley D. Frey,(unknown),Priscila Ferreira Slepicka,(unknown),(unknown),William C. K. Pomerantz,Gregory J. Hannon,Camila O. dos Santos	38

About William C. K. Pomerantz

William C. K. Pomerantz is a scholar working on Hematology, Chemical Health and Safety and Molecular Biology, having authored 99 papers that have together received 2.9k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (34 papers), Multiple Myeloma Research and Treatments (23 papers) and Ubiquitin and proteasome pathways (18 papers). The work is most often cited by research in Microbiology (255 citations), Molecular Biology (1.9k citations) and Organic Chemistry (790 citations). William C. K. Pomerantz has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Samuel H. Gellman, Karen Bulloch, Nicholas L. Abbott, Clifford T. Gee, Andrew K. Urick, Sean P. Palecek, Amy J. Karlsson, Neeraj K. Mishra, Manuel M. Müller and Donald Hilvert. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and The Journal of Chemical Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact